0001411207-19-000209.txt : 20191112 0001411207-19-000209.hdr.sgml : 20191112 20191112140516 ACCESSION NUMBER: 0001411207-19-000209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191108 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASKREN STANLEY A CENTRAL INDEX KEY: 0001195347 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35456 FILM NUMBER: 191208507 MAIL ADDRESS: STREET 1: 408 EAST SECOND STREET CITY: MUSCATINE STATE: IA ZIP: 52761 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allison Transmission Holdings Inc CENTRAL INDEX KEY: 0001411207 STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLE PARTS & ACCESSORIES [3714] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE ALLISON WAY CITY: Indianapolis STATE: IN ZIP: 46222 BUSINESS PHONE: (317) 242-5000 MAIL ADDRESS: STREET 1: ONE ALLISON WAY CITY: Indianapolis STATE: IN ZIP: 46222 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-11-08 0001411207 Allison Transmission Holdings Inc ALSN 0001195347 ASKREN STANLEY A ONE ALLISON WAY INDIANAPOLIS IN 46222 1 0 0 0 Deferred Stock Units 2019-11-08 4 A 0 454 0 A Common Stock 454 3824 D These deferred stock units ("DSUs") respresent a quarterly payment of the reporting person's annual retainer under the Allison Transmission Holdings, Inc. (the "Company") Third Amended and Restated Non-Employee Director Compensation Policy ("Policy") deferred pursuant to the Company's Amended and Restated Non-Employee Director Deferred Compensation Plan. The annual retainer is paid quarterly in arrears. Each DSU is the economic equivalent of one share of the Company's Common Stock. The DSUs become payable, in common stock or at the Company's election cash, at the earlier of the reporting person's separation from service or a change in control. DSUs earn dividend equivalents when dividends are declared on the Company's common stock. The number of DSUs received was calculated based on $46.75, which was the closing price of the Company's common stock on the date of grant. /s/Jacalyn C. Bolles, Attorney-in-Fact 2019-11-12